Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy

Ann Oncol. 1996 Jul;7(5):538. doi: 10.1093/oxfordjournals.annonc.a010650.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Drug Therapy, Combination
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / pathology
  • Humans
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use*
  • Isotretinoin / administration & dosage
  • Isotretinoin / therapeutic use*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Interferon-alpha
  • Isotretinoin